GlassScriptPhysician profile
Daniel T Kuesis
NPI 1679573240
$10,980.25
in general payments reported to CMS, 2019-2025
19 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,663 · 2020: $236 · 2021: $1,869 · 2022: $2,706 · 2023: $295 · 2024: $99.99 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409 · Debt Forgiveness: $98.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.76 |
| Debt Forgiveness | $98.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,944.91 | 2019-2024 | Pico 14, Pico 7 |
| Stryker Corporation | $2,885.13 | 2019-2024 | Mako |
| Zimmer Biomet Holdings, INC. | $235.89 | 2019-2023 | Rosa |
| Linvatec Corporation | $132.44 | 2019 | |
| Depuy Synthes Sales INC. | $124.18 | 2020 | |
| Djo, LLC | $98.67 | 2023 | |
| Davol INC. | $93.15 | 2019 | |
| Horizon Therapeutics Plc | $91.92 | 2019-2020 | |
| Heraeus Medical, LLC. | $65.74 | 2021-2025 | |
| Heron Therapeutics, INC. | $53.47 | 2023-2025 | Zynrelef |
| Sanofi-Aventis U.S. LLC | $49.74 | 2019-2020 | |
| Vericel Corporation | $48.09 | 2019-2023 | Maci |
| Pacira Therapeutics, INC. | $32.86 | 2019 | |
| Medtronic, INC. | $29.03 | 2025 | Medtronic Reusable Instruments |
| Fidia Pharma USA INC. | $26.32 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $20.81 | 2025 | |
| Csl Behring | $18.91 | 2020 | |
| Zyla Life Sciences, INC. | $17.62 | 2019 | |
| Amgen INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kuesis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.